Blood glucose testing at regular intervals is very crucial for diabetic patients, in order to keep a track of fluctuating glucose levels in the blood. The crucial aim of diabetes treatment is to ensure normal levels of blood glucose. Hemoglobin A1c (Hb A1c) is a lab test that gives an idea about average levels of blood sugar for a period of around three months. The test results give an idea about the efficacy of diabetes treatment plans. It provides insights on the following parameters:
- Success of the designed diabetes treatment plan.
- Accuracy of test results
The mechanism of test includes linking of hemoglobin to glucose molecules in red blood cells. With increasing levels of glucose in red blood cells, there is a high possibility of hemoglobin molecules being glycated or linked with glucose molecules. It is recommended to perform the test atleast twice in a year. A1c levels are reported in terms of percentages. Presently, American Association of Clinical Endocrinologists recommends around 6.5% A1c to be normal concentration and American Diabetes Association recommends less than 7.0% A1c in the blood cells.
The market for hemoglobin A1c testing is witnessing a consistent growth trend majorly due to increasing incidence of diabetes mellitus across the globe. According to the data enumerated by WHO, there are around 347 million diabetic patients worldwide and diabetes will be seventh leading cause of death by 2030. Currently, with the approval of U.S. FDA for these tests or assays for diagnosing diabetes by healthcare professionals, the demand and acceptance of HbA1c tests will further increase.
Some of the major factors fueling the market growth are increased demand for continuous monitoring and management of diabetes worldwide and focus on the development of technologically sound and portable monitoring devices. In addition, higher efficiency of these devices followed by the ease of use, high reliability and quick results further augment the market growth. Negligence for testing in low income nations and lack of appropriate awareness about these tests might hamper the market growth. Some of the major market players competing in this market are Abbott Laboratories, Bayer Healthcare Diagnostics, Bio-Rad Laboratories, Inc., and Siemens AG.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Browse Upcoming Reports @:http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY - 12207